To determine whether the effects on cell viability in AML cells were related to the specific cancer subtypes, or to differences in temporal response to DJ4, we examined whether DJ4 affected the viability of various NSCLC cells over longer periods of drug exposure. The gene discussed is DNAJB6; the disease is acute myeloid leukemia.